AlzeCure Pharma AB, a Swedish pharmaceutical company focused on Alzheimer’s disease and pain, has appointed Martin Jönsson as chief executive. He replaces Johan Sandin, a company founder, who will stay with the organisation as chief scientific officer. Mr Jönsson was previously an executive at Ferring Pharmaceuticals Inc and before that, worked in business development at Roche. He joins AlzeCure as the company prepares to bring two candidate drugs to the clinic by the end of 2020.
AlzeCure Pharma announced the appointment on 8 January 2020
Copyright 2020 Evernow Publishing Ltd